:: Library Catalog

Buchumschlag

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Lucas Sabatella, Patricia M. Ortega, Víctor Valentí Azcárate, Fernando Rotellar Sastre, Adriana Uriz Pagola, Ahmed Ahmed, Sanjay Purkayastha, Carlota Tuero Ojanguren, Nuria Blanco Asensio, Manuel F. Landecho
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	Obesity
Online-Zugang:	https://onlinelibrary.wiley.com/doi/10.1002/oby.70100
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

GLP ‐1 Receptor Agonists and Weight Loss Among Suboptimal Responders to Metabolic Bariatric Surgery: A Target Trial Emulation
von: Haisheng Wu, et al.
Veröffentlicht: (2026)

Weight Loss Outcomes Between GLP ‐1 Receptor Agonists and Bariatric Surgery in Adults With Obesity: A Systematic Review, Meta‐Analysis and Meta‐Regression
von: Muhammad Tahir, et al.
Veröffentlicht: (2026)

Severe Alcohol‐Related Liver Disease Following Bariatric Surgery
von: Ahmed Ibrahim, et al.
Veröffentlicht: (2025)

Cancer Risk—Comparing Metabolic Bariatric Surgery and the General Population
von: Lance E. Davidson, et al.
Veröffentlicht: (2025)

Lipoedema and Bariatric and Metabolic Surgery: A Systematic Review
von: Qamil Pajaziti, et al.
Veröffentlicht: (2025)

Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
von: Roberta Scairati, et al.
Veröffentlicht: (2026)

GLP‐1 Receptor Agonists and Weight Loss: A Critical Review of Mechanisms
von: Giorgia Rutigliani, et al.
Veröffentlicht: (2026)

Sarcopenic Obesity in Metabolic and Bariatric Surgery: A Scoping Review
von: Flavio T. Vieira, et al.
Veröffentlicht: (2025)

Racial Disparities in Paediatric Metabolic and Bariatric Surgery: An MBSAQIP Analysis
von: Zachary Ballinger, et al.
Veröffentlicht: (2025)

Efficacy and Safety of GLP ‐1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMA
von: Binayak Sinha, et al.
Veröffentlicht: (2025)

Micronutrient and Nutritional Deficiencies Associated With GLP ‐1 Receptor Agonist Therapy: A Narrative Review
von: Jorge Urbina, et al.
Veröffentlicht: (2026)

Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
von: Inyoung Hwang, et al.
Veröffentlicht: (2026)

Long‐Term Experience of Undergoing Metabolic and Bariatric Surgery as an Adolescent
von: Malin Örn, et al.
Veröffentlicht: (2025)

One Year of Exercise After Weight Loss Increases Postprandial GLP ‐1 Secretion in Contrast to Usual Activity or GLP ‐1 Receptor Agonist Treatment
von: Joachim Holt, et al.
Veröffentlicht: (2025)

Safety and Cost‐Effectiveness of Early Discharge Following Bariatric Surgery in an Underserved Urban Population
von: Dimitri Chepkunov, et al.
Veröffentlicht: (2026)

Enhancing Shared Decision‐Making in Metabolic and Bariatric Surgery: A Multi‐System Implementation and Evaluation
von: David E. Arterburn, et al.
Veröffentlicht: (2025)

GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
von: Cynthia F. X. C. A. Silva, et al.
Veröffentlicht: (2026)

Bone Health After Metabolic and Bariatric Surgery: Osteometabolism Biomarkers, Bone Mineral Density, and Microarchitecture
von: Camila Medeiros de Almeida, et al.
Veröffentlicht: (2026)

GLP‐1 Receptor Agonists and Substance Use Disorders in Older Adults With Type 2 Diabetes: A Target Trial Emulation
von: Hao Dai, et al.
Veröffentlicht: (2025)

Joint Pain Outcomes After Metabolic and Bariatric Surgery in Patients With and Without Hypermobility
von: Elke Schubert‐Hjalmarsson, et al.
Veröffentlicht: (2026)

A Longitudinal Mediation Analysis of Quality of Life After Metabolic and Bariatric Surgery
von: Maria Rosaria Magurano, et al.
Veröffentlicht: (2026)

Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
von: Lasin Ozbek, et al.
Veröffentlicht: (2026)

Impact of GLP ‐1 Receptor Agonist Discontinuation on Liver‐Related Parameters: A Systematic Review and Meta‐Analysis
von: Matheus Souza, et al.
Veröffentlicht: (2026)

GLP ‐1 Receptor/Dual Agonists for Weight Loss: A Systematic Review and Network Meta‐Analysis of RCTs
von: Jirawan Vienghirun, et al.
Veröffentlicht: (2026)

Psychiatric and Cognitive Functioning After Metabolic and Bariatric Surgery: A Systematic Review and Meta‐Analysis
von: Emma A. van Reekum, et al.
Veröffentlicht: (2025)

A 10‐Year Update: Bibliometric Analysis of the Top 100 Papers in Metabolic and Bariatric Surgery
von: Florina Corpodean, et al.
Veröffentlicht: (2026)

Preoperative Comorbidities Associated With Weight Loss Following Metabolic and Bariatric Surgery: A Rapid Review
von: Evan Atlantis, et al.
Veröffentlicht: (2025)

Motivators and Barriers to Seeking Metabolic and Bariatric Surgery Among Adolescents: A Qualitative Study
von: Marlyn A. Allicock, et al.
Veröffentlicht: (2025)

Economic Evaluation of the Metabolic and Bariatric Surgery Initiative for Patients With Obesity and Comorbid Diabetes in Queensland
von: Paul Scuffham, et al.
Veröffentlicht: (2026)

Trends in Use of Obesity Medications and Metabolic and Bariatric Surgery Among All of Us Participants From 2003 to 2023
von: Olajide A. Adekunle, et al.
Veröffentlicht: (2026)

Musculoskeletal Outcomes of Glucagon‐Like Peptide‐1 Receptor Agonists Versus Other Antiobesity Agents in Nondiabetic Adults
von: Jie‐Syuan Wu, et al.
Veröffentlicht: (2026)

Naltrexone/Bupropion, Liraglutide, or Semaglutide as Adjuvant Therapy After Metabolic and Bariatric Surgery: An Observational Study
von: Anthony Brancatisano, et al.
Veröffentlicht: (2025)

Relationships Between Metabolic and Bariatric Surgery and Adverse Kidney Outcomes: An Analysis of a Retrospective Cohort
von: Kevin C. Maki, et al.
Veröffentlicht: (2025)

Association of GLP ‐1 Receptor Agonist Use With Safety Outcomes in Individuals With Opioid Use Disorder: A Target Trial Emulation
von: Tahmid Hussain, et al.
Veröffentlicht: (2026)

Patient Perspectives on the Course of Alcohol Use After Metabolic and Bariatric Surgery: Implications for Prevention, Intervention, and Future Research
von: Erin N. Haley, et al.
Veröffentlicht: (2025)

Weekly Subcutaneous VK2735 , a GIP / GLP ‐1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13‐Week VENTURE Study
von: Harold E. Bays, et al.
Veröffentlicht: (2026)

The Interplay Between Social Factors and Metabolic Bariatric Surgery Outcomes—A 5‐Year Prospective Study
von: Uta Sailer, et al.
Veröffentlicht: (2025)

Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials
von: Rayanne Santos de Paulo, et al.
Veröffentlicht: (2026)

GLP‐1 Receptor Agonist Medications for Obesity and Type 2 Diabetes Treatment: A Rapid Review of Changes in Eating Behaviors and Eating Disorder Risk
von: Hiba Jebeile, et al.
Veröffentlicht: (2025)

Transforming Treatment: The Impact of Bariatric Surgery on Oral Drug Absorption
von: Danielle Wigg, et al.
Veröffentlicht: (2025)